Inclusion criteria:
- Phototype Skin II and III Integral skin test in the region
- Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;
Exclusion criteria:
- Lactation or pregnancy
- Use of Antiinflammatory 30 days and/or immunossupression drugs for until 03 months before volunteers selection
- Use of Antihistamines 30 days before selection
- Disease which can cause immunosuppresion, such as diabetes, HIV
- Use of photosensitivity drugs
- History of sensitivity or photosensitivity for topic products
- Cutaneous active disease which can modify the study results
- History or activity of photodermatosis
- Personal or family antecedents of cutaneous neoplasia photo induced
- Presence of injury precursor of cutaneous neoplasia, such as melanociticos nevus and actinic keratosis
- Intense exposure solar in the test region
- Use of new drugs and/or cosmetics during the study
- Previous participation in studies using the same product in test
- Relevant history or confirmation of alcohol or other drugs abuse
- Intolerance detected or suspected for some component of the sample tested
- Medecin or sponsor employees or their close family.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.